Alpa Laboratories (NSE:ALPA) EV-to-OCF: (As of Sep. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
75 GF Score
Price ₹61.69
GF Value ₹93.76
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alpa Laboratories EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Alpa Laboratories's Enterprise Value is ₹-52 Mil. Alpa Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil. Therefore, Alpa Laboratories's EV-to-OCF for today is .

The historical rank and industry rank for Alpa Laboratories's EV-to-OCF or its related term are showing as below:

NSE:ALPA's EV-to-OCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 10.305
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-09-12), Alpa Laboratories's stock price is ₹61.69. Alpa Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹1.680. Therefore, Alpa Laboratories's PE Ratio (TTM) for today is 36.72.


Alpa Laboratories  (NSE:ALPA) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Alpa Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=61.69/1.680
=36.72

Alpa Laboratories's share price for today is ₹61.69.
Alpa Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.680.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Alpa Laboratories EV-to-OCF Related Terms


Alpa Laboratories EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Alpa Laboratories's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories EV-to-OCF Chart

Alpa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.23 3.89 24.09 5.81 -4.10

Alpa Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -4.10 0.00

NSE:ALPA vs ZTS: EV-to-OCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alpa Laboratories's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpa Laboratories EV-to-OCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpa Laboratories's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Alpa Laboratories's EV-to-OCF falls into.


NSE:ALPA
75GF Score
Alpa Laboratories Ltd NSE:ALPA
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpa Laboratories EV-to-OCF Calculation

Alpa Laboratories's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=-52.380/0
=

Alpa Laboratories's current Enterprise Value is ₹-52 Mil.
Alpa Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹61.69 is trading 34.2% below its estimated GF Value™ of ₹93.76. GuruFocus considers Alpa Laboratories to be Significantly Undervalued.

Key valuation signals for NSE:ALPA:

  • EV-to-OCF:
  • GF Value™: ₹93.76 vs. price of ₹61.69 (34.2% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
75GF Score

Get the complete analysis for NSE:ALPA

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹61.69
Price
₹93.76
GF Value